These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6011791)

  • 1. Considerations for the pre-clinical evaluation of new psychiatric drugs: a case study with phenothiazine-like tranquilizers.
    Irwin S
    Psychopharmacologia; 1966; 9(4):259-87. PubMed ID: 6011791
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological studies with some newly synthesized phenothiazines exhibiting lesser extrapyramidal reactions.
    Sharma VN; Mital RL; Banerjee SP; Sharma HL
    Jpn J Pharmacol; 1969 Jun; 19(2):211-23. PubMed ID: 5308826
    [No Abstract]   [Full Text] [Related]  

  • 3. The prediction of sedative potency of neuroleptics.
    Loew DM
    Mod Probl Pharmacopsychiatry; 1970; 5():47-50. PubMed ID: 5527167
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study on the extrapyramidal system from the standpoint of pharmacology and psychopharmacology].
    Hara S
    Zasshi Tokyo Ika Daigaku; 1969 Jan; 27(1):1-22. PubMed ID: 4978901
    [No Abstract]   [Full Text] [Related]  

  • 5. Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? IV. An improved experimental design for measuring the inhibitory effects of neuroleptic drugs on amphetamine-or apomorphine-induced "Cheroing" and "agitation" in rats.
    Janssen PA; Niemegeers CJ; Schellekens KH; Lenaerts FM
    Arzneimittelforschung; 1967 Jul; 17(7):841-54. PubMed ID: 5632842
    [No Abstract]   [Full Text] [Related]  

  • 6. The comparative pharmacology of flupenthixol and some reference neuroleptics.
    Nielsen IM; Pedersen V; Nymark M; Franck KF; Boeck V; Fjalland B; Christensen AV
    Acta Pharmacol Toxicol (Copenh); 1973; 33(5):353-62. PubMed ID: 4801081
    [No Abstract]   [Full Text] [Related]  

  • 7. Phenothiazine depression of approach and avoidance behavior.
    Ray OS; Bivens LW
    Psychopharmacologia; 1967; 10(3):196-203. PubMed ID: 5626645
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug therapy.
    Stone WN; Hofling CK; Winslow WW
    Prog Neurol Psychiatry; 1968; 23():563-81. PubMed ID: 4890081
    [No Abstract]   [Full Text] [Related]  

  • 9. [Influence of Lysoneuro on the spontaneous behavior of experimental animals].
    D'Atri G; Galimberti E
    Minerva Med; 1972 Jan; 63(2):55-70. PubMed ID: 5062109
    [No Abstract]   [Full Text] [Related]  

  • 10. Phenothiazine toxicity in paediatric practice with three case reports.
    Bajpai PC; Sethi VK; Pathak AK; Tripathi TK
    Indian Pediatr; 1969 Jul; 6(7):470-5. PubMed ID: 5345025
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacological vs. clinical physiognomy of neuroleptics, with special reference to their sedative and antipsychotic effects.
    Nielsen IM
    Acta Psychiatr Belg; 1974 Sep; 74(5):473-84. PubMed ID: 4471027
    [No Abstract]   [Full Text] [Related]  

  • 12. [Neuroleptic therapy of schizophrenia from pharmacological viewpoint].
    Stille G
    Schweiz Med Wochenschr; 1969 Nov; 99(46):1645-52 contd. PubMed ID: 4391348
    [No Abstract]   [Full Text] [Related]  

  • 13. [Longitudinal profiles of the effects of psychotropic drugs. Animal experimental findings].
    Kreiskott H
    Arzneimittelforschung; 1974 Jul; 24(7):974-6. PubMed ID: 4408071
    [No Abstract]   [Full Text] [Related]  

  • 14. Chlorpromazine and the eye of the dog. VI. A comparison of phenothiazine tranquilizers.
    Barron CN; Murchison TE; Rubin LF; Rubin ML; Herron W; Muscarella M; Birkhead H
    Exp Mol Pathol; 1972 Apr; 16(2):172-9. PubMed ID: 5062562
    [No Abstract]   [Full Text] [Related]  

  • 15. Side-effects of phenothiazines.
    Lowther J
    Br J Psychiatry; 1967 May; 113(498):557-8. PubMed ID: 6033501
    [No Abstract]   [Full Text] [Related]  

  • 16. [Content of catecholamines in the brain stem of albino rats and sedative affect of some tranquilizing agents].
    Vysotskais NB; Shugina TM
    Farmakol Toksikol; 1967; 30(5):553-6. PubMed ID: 5628420
    [No Abstract]   [Full Text] [Related]  

  • 17. Catalepsy and circling behaviour after intracerebral injections of neuroleptic, cholinergic and anticholinergic agents into the caudate-putamen, globus pallidus and substantia nigra of rat brain.
    Costall B; Naylor RJ; Olley JE
    Neuropharmacology; 1972 Sep; 11(5):645-63. PubMed ID: 4597256
    [No Abstract]   [Full Text] [Related]  

  • 18. Psychotropic drugs used in the management of schizophrenia.
    Bueno JR; Himwich HE
    Int J Neurol; 1967; 6(1):77-93. PubMed ID: 5630202
    [No Abstract]   [Full Text] [Related]  

  • 19. [2-ethylamino-6-chloro-4-methyl-4-phenyl-4H-3,1-benzoxazine, a new psychotropic compound].
    Hoffmann I; Kuch H; Schmitt K; Seidl G
    Arzneimittelforschung; 1970 Jul; 20(7):975. PubMed ID: 5536073
    [No Abstract]   [Full Text] [Related]  

  • 20. Antischizophrenic drugs and brain cholinergic receptors. Affinity for muscarinic sites predicts extrapyramidal effects.
    Snyder S; Greenberg D; Yamamura HI
    Arch Gen Psychiatry; 1974 Jul; 31(1):58-61. PubMed ID: 4152054
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.